Wet cupping therapy and acupuncture applications in migraine patients: A randomized controlled trial
Abstract
AIM
Although there are numerous complementary treatments for migraine, comparisons among themselves are relatively rare. This study aimed to investigate and compare the effectiveness of wet cupping therapy (WCT) and acupuncture applications in treating migraine patients.
MATERIALS AND METHOD
This was a randomized controlled clinical trial conducted between 01.03.2022 and 01.10.2023 in the Traditional and Complementary Medicine Center of a tertiary hospital. Patients diagnosed with migraine were included in the study and randomized into three arms. The WCT group received cupping 3 times, once a month. The acupuncture group received 10 sessions of acupuncture once a week. The waiting list was assigned as the control group. VAS and MIDAS scales were applied to all groups at the beginning and the end of the treatment, and the results were compared.
RESULTS
All three groups were similar regarding age and sex. Migraine Disability Assessment Scale (MIDAS) and Visual Analogue Scale (VAS) pain scores decreased significantly in both treatment groups after the applications, while they remained similar for the same period in the control group. Additionally, the post-treatment values of MIDAS and VAS in both the WCT and acupuncture groups were significantly lower compared to controls, while they were similar when compared in between.
CONCLUSION
Both of these applications were found to be similarly effective in improving disability status and pain intensity in patients with migraine.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.